Emergent Biosolutions EBS Finished goods
Finished goods at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:InventoryFinishedGoodsNetOfReserves.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's finished goods.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's finished goods?
- Emergent Biosolutions (EBS) reported finished goods of $133M in Q1 2026.
- How has Emergent Biosolutions's finished goods changed year-over-year?
- Emergent Biosolutions's finished goods increased by 11.8% year-over-year, from $119M to $133M.
- What is the long-term trend for Emergent Biosolutions's finished goods?
- Over 5 years (2020 to 2025), Emergent Biosolutions's finished goods has grown at a 21.0% compound annual growth rate (CAGR), from $43.9M to $113.8M.
- What does finished goods mean?
- Completed products ready for sale, valued at the lower of cost or net realizable value.